Company / Assets per Share
ImmunityBio, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.59
FY2025
5-year range
$0.57 / $1.23
FY2021-FY2025
Trend
+3.1%
vs FY2024
Sector context
#205 of 210
Health Care
What the data says
Among 210 Health Care companies, ImmunityBio, Inc. is in the bottom 2% for assets per share. Assets per Share has fluctuated over the past 10 years, ranging from $0.57 in FY2024 to $3.90 in FY2016.
Based on SEC 10-K filings.
0.59 in FY2025 with a 5-year CAGR of -23.5%.
Declined from $1.20 to $0.59 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.6%
- 5-Year CAGR
- -23.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 210This company $0.59 Sector average $296.79
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 3.1% year-over-year.
- Ranks #205 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2016.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.59 | +3.1% |
| FY2024 | $0.57 | -52.3% |
| FY2023 | $1.20 | +31.4% |
| FY2022 | $0.91 | -25.8% |
| FY2021 | $1.23 | -45.4% |
| FY2020 | $2.25 | +24.2% |
| FY2019 | $1.81 | -21.4% |
| FY2018 | $2.30 | -24.6% |
| FY2017 | $3.05 | -21.8% |
| FY2016 | $3.90 | -99.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026